Stay updated on Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.

Latest updates to the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a note in Publications indicating that publications are provided voluntarily and pertain to study results. Updated the revision tag to Revision: v3.3.2 and removed the older Revision: v3.2.0.SummaryDifference0.1%

- Check19 days agoChange DetectedThe funding/operating status notice banner was removed. Other trial details and contact information remain unchanged.SummaryDifference0.4%

- Check33 days agoChange DetectedThe study details page for NCT03721679 appears unchanged between versions, with core content and structure the same and no additions or deletions detected.SummaryDifference0.5%

- Check62 days agoChange DetectedUpdated operating-status notice and version to v3.2.0; removed v3.1.0.SummaryDifference3%

- Check69 days agoChange DetectedThe page now shows Revision: v3.1.0 and no longer shows Revision: v3.0.2, indicating an update to the software version tag.SummaryDifference0.1%

- Check83 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.